OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Showing 1-25 of 33 citing articles:

NSAID (nonsteroidal anti-inflammatory drugs) Induced Stevens Johnson Syndrome in a 50-year-old woman: A case study
Navid Faraji, Rasoul Goli, Pariya Mohsennezhad, et al.
Toxicology Reports (2024) Vol. 12, pp. 289-291
Open Access | Times Cited: 4

Neutrophil‐driven and interleukin‐36γ‐associated ocular surface inflammation in chronic Stevens–Johnson syndrome
Madhuri Amulya Koduri, Tejaswini Pingali, Deeksha Prasad, et al.
Allergy (2024) Vol. 79, Iss. 8, pp. 2128-2143
Open Access | Times Cited: 4

Update on Stevens–Johnson Syndrome and Toxic Epidermal Necrolysis: Diagnosis and Management
Hemali Shah, Rose Parisi, Eric Mukherjee, et al.
American Journal of Clinical Dermatology (2024)
Open Access | Times Cited: 4

The Potential Roles of IL-1β, IL-6, and RIPK3 in the Pathogenesis of Stevens–Johnson Syndrome/Toxic Epidermal Necrolysis
Chandana Sooranahalli, Vidhya R. Rao, Brandon Zelman, et al.
Diagnostics (2025) Vol. 15, Iss. 3, pp. 290-290
Open Access

Latin American guidelines for the diagnosis and treatment of Stevens-Johnson syndrome and toxic epidermal necrolysis
Andrea Dionelly Murillo-Casas, Ricardo Zwiener, Pedro Giavina‐Bianchi, et al.
World Allergy Organization Journal (2025) Vol. 18, Iss. 4, pp. 101046-101046
Open Access

Correlations between histopathologic findings, serum biomarker levels, and clinical outcomes in Stevens–Johnson syndrome/toxic epidermal necrolysis (SJS/TEN)
Donlaporn Chuenwipasakul, Chanudda Washrawirul, Rawiphan Panpruk, et al.
Scientific Reports (2023) Vol. 13, Iss. 1
Open Access | Times Cited: 8

Greater mechanistic understanding of the cutaneous pathogenesis of Stevens–Johnson syndrome/toxic epidermal necrolysis can shed light on novel therapeutic strategies: a comprehensive review
Emeka Ogiji, Nourah Aboheimed, Kehinde Ross, et al.
Current Opinion in Allergy and Clinical Immunology (2024) Vol. 24, Iss. 4, pp. 218-227
Open Access | Times Cited: 2

Characteristics of adverse drug reactions due to nonsteroidal anti-inflammatory drugs: a cross-sectional study.
Cholticha Sonsupap, Pattreya Pokhakul, Tetsuyoshi Kariya, et al.
PubMed (2023) Vol. 85, Iss. 4, pp. 668-681
Closed Access | Times Cited: 6

Granzyme B as a therapeutic target: an update in 2022
Alexandre Aubert, Michael D. Lane, Karen Jung, et al.
Expert Opinion on Therapeutic Targets (2022) Vol. 26, Iss. 11, pp. 979-993
Closed Access | Times Cited: 9

Erythema multiforme in children
Ran D. Goldman
Canadian Family Physician (2022) Vol. 68, Iss. 7, pp. 507-508
Open Access | Times Cited: 8

Paracetamol (Acetaminophen)-associated SJS, TEN, AGEP, and DRESS Syndromes - A Narrative Review
Naina Mohamed Pakkir Maideen, Ibrahim Ramadan Barakat, Abdurazak Jumale
Current Drug Safety (2023) Vol. 19, Iss. 2, pp. 218-223
Closed Access | Times Cited: 4

A systematic review of case–control studies of cytokines in blister fluid and skin tissue of patients with Stevens Johnson syndrome and toxic epidermal necrolysis
Thomas Stewart, Joshua R. Farrell, John W. Frew
Australasian Journal of Dermatology (2024) Vol. 65, Iss. 6, pp. 491-504
Closed Access | Times Cited: 1

Moderate and serious adverse reactions to antimicrobials among hospitalized children: A systematic review
Sheila Feitosa Ramos, Letícia Gomes do Sacramento, Rafaella Oliveira Santos de Silva, et al.
British Journal of Clinical Pharmacology (2024) Vol. 90, Iss. 9, pp. 2092-2110
Closed Access | Times Cited: 1

Effectiveness and Safety of Early Short-Course, Moderate- to High-Dose Glucocorticoids for the Treatment of Stevens–Johnson Syndrome/Toxic Epidermal Necrolysis: A Retrospective Study
Zhenzhen Ye, Chunting Li, Hua Zhang, et al.
Clinical Cosmetic and Investigational Dermatology (2022) Vol. Volume 15, pp. 1979-1990
Open Access | Times Cited: 7

Stevens-Johnson Syndrome From Combined Allopurinol and Angiotensin-Converting Enzyme Inhibitors: A Narrative Review
Isabella M Fabian, Kirsten Maddox, Cameron Robicheaux, et al.
Cureus (2024)
Open Access | Times Cited: 1

Stevens-Johnson syndrome/TEN induced by lamotrigine in a patient with a cerebral cavernous malformation: a case report
Cristina Frattini, Alberto Corrà, Elena Biancamaria Mariotti, et al.
Dermatology Reports (2024)
Open Access | Times Cited: 1

Cutaneous Stevens Johnson – Toxic Epidermal Necrolysis Immunotherapy related Toxicities in Lung Cancer Patients
Dimitrios Alexandris, Nektarios Alevizopoulos, Harikleia Gakiopoulou, et al.
Journal of Oncology Pharmacy Practice (2022) Vol. 28, Iss. 5, pp. 1276-1282
Closed Access | Times Cited: 6

Stevens-Johnson Syndrome in Adult Patient Secondary to COVID-19 Infection: Case Report
Pandharinath Khade, Avani Shah, Vidya Kharkar
JMIR Dermatology (2023) Vol. 6, pp. e45062-e45062
Open Access | Times Cited: 3

Komplikasi Sindrom Stevens-Johnson (SSJ) dan Nekrolisis Epidermal Toksik (NET)
Aribowo I Kadek, Angel Benny Wisan
Cermin Dunia Kedokteran (2024) Vol. 51, Iss. 2, pp. 71-75
Open Access

Unusual Manifestation of Post-Infectious Erythema Multiforme
Kaoutar Danaoui, Marouane Jakani, Imane Fetoui, et al.
SAS Journal of Medicine (2024) Vol. 10, Iss. 04, pp. 238-241
Open Access

Acute and chronic ocular outcomes in SJS/TEN patients treated with oral ciclosporin vs intravenous immunoglobulin
Valencia Hui Xian Foo, Haur Yueh Lee, Jodhbir S. Mehta, et al.
Frontiers in Medicine (2024) Vol. 11
Open Access

Exploring Drug-Induced Toxic Epidermal Necrolysis: A Case Series and Comprehensive Review
S. Karanam, Praveen Kumar Uppala, Nagavishnu Kandra
Allergy medicine. (2024) Vol. 3, pp. 100011-100011
Open Access

Page 1 - Next Page

Scroll to top